Contributing
to society
with new
pharmaceuticals
- Global Health
- Activities
- International Affairs Committee(Asia Committee)
- Deliverables of Drug Evaluation Committee
- Quality & Technology Committee
- JPMA Statement on WTO TRIPS Intellectual Property Waiver
- UN Climate Change Conference (COP26): Biopharmaceutical Industry Actions to Tackle Climate Change
- Three priorities to urgently increase access to COVID-19 vaccines
- Statement by JPMA President on the Passing of Former Prime Minister ABE Shinzo
- Opinion on Access and Benefit Sharing of Digital Sequence Information
- Code
- About Us
- ICH Project
- News Room
